Aclaris Historical Balance Sheet

ACRS Stock

USD 1.64 0.02 1.23%

Trend analysis of Aclaris Therapeutics balance sheet accounts such as Other Current Liab of 24.2 M, Total Current Liabilities of 17.8 M or Total Stockholder Equity of 136.4 M provides information on Aclaris Therapeutics' total assets, liabilities, and equity, which is the actual value of Aclaris Therapeutics to its prevalent stockholders. By breaking down trends over time using Aclaris Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Aclaris Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aclaris Therapeutics is a good buy for the upcoming year.

Aclaris Therapeutics Inventory

(10.47 Million)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.

About Aclaris Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Aclaris Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Aclaris Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Aclaris Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Aclaris currently owns. An asset can also be divided into two categories, current and non-current.

Aclaris Therapeutics Balance Sheet Chart

At this time, Aclaris Therapeutics' Accumulated Other Comprehensive Income is comparatively stable compared to the past year. Property Plant Equipment is likely to gain to about 1.9 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 17.8 M in 2025.

Total Assets Other Current Liab Total Current Liabilities Other Liab

Add Fundamental

Total Assets

Total assets refers to the total amount of Aclaris Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Aclaris Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Aclaris Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Aclaris Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Aclaris Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Aclaris Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.At this time, Aclaris Therapeutics' Accumulated Other Comprehensive Income is comparatively stable compared to the past year. Property Plant Equipment is likely to gain to about 1.9 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 17.8 M in 2025.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	10.2M	2.2M	23.0M	24.2M
Total Assets	254.6M	197.4M	220.3M	175.4M

Other Current Liab Total Assets

Aclaris Therapeutics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Property Plant Equipment	Net Tangible Assets	Non Currrent Assets Other	Other Assets	Deferred Long Term Liab	Long Term Investments
Total Assets		0.62	0.8	0.99	0.62	0.66	-0.44	-0.63	0.82	0.49	0.71	0.94	0.71	0.93	0.06	0.73	0.79	0.55	0.82	0.96	0.26	0.97	0.21	0.41	0.61	0.48
Other Current Liab	0.62		0.67	0.55	0.77	0.42	-0.05	-0.81	0.5	0.07	0.83	0.49	0.67	0.49	0.37	0.58	0.7	0.66	0.67	0.51	0.23	0.61	0.83	0.22	0.61	0.75
Total Current Liabilities	0.8	0.67		0.72	0.73	0.71	-0.19	-0.87	0.84	0.24	0.8	0.61	0.92	0.58	0.17	0.7	0.95	0.75	0.96	0.65	0.51	0.79	0.42	0.3	0.91	0.55
Total Stockholder Equity	0.99	0.55	0.72		0.54	0.62	-0.51	-0.55	0.78	0.54	0.64	0.96	0.63	0.95	-0.09	0.66	0.72	0.4	0.74	0.98	0.26	0.97	0.13	0.37	0.52	0.46
Other Liab	0.62	0.77	0.73	0.54		0.18	-0.03	-0.93	0.46	0.0	0.72	0.53	0.87	0.54	0.31	0.75	0.85	0.67	0.83	0.54	0.06	0.65	0.68	0.24	0.54	0.83
Property Plant And Equipment Net	0.66	0.42	0.71	0.62	0.18		-0.37	-0.41	0.89	0.48	0.64	0.51	0.42	0.47	0.03	0.31	0.5	0.47	0.57	0.55	0.65	0.55	0.11	0.24	0.78	0.07
Net Debt	-0.44	-0.05	-0.19	-0.51	-0.03	-0.37		0.05	-0.33	-0.99	-0.12	-0.49	-0.15	-0.56	0.33	-0.14	-0.19	0.1	-0.17	-0.5	-0.25	-0.43	0.06	0.06	-0.02	-0.02
Retained Earnings	-0.63	-0.81	-0.87	-0.55	-0.93	-0.41	0.05		-0.61	-0.05	-0.76	-0.5	-0.94	-0.49	-0.22	-0.71	-0.93	-0.69	-0.88	-0.53	-0.35	-0.66	-0.66	-0.2	-0.77	-0.76
Accounts Payable	0.82	0.5	0.84	0.78	0.46	0.89	-0.33	-0.61		0.41	0.65	0.73	0.66	0.69	0.14	0.62	0.72	0.63	0.79	0.76	0.6	0.72	0.11	0.41	0.86	0.2
Cash	0.49	0.07	0.24	0.54	0.0	0.48	-0.99	-0.05	0.41		0.18	0.51	0.15	0.57	-0.28	0.14	0.21	-0.04	0.2	0.53	0.27	0.45	-0.09	-0.03	0.1	-0.03
Non Current Assets Total	0.71	0.83	0.8	0.64	0.72	0.64	-0.12	-0.76	0.65	0.18		0.49	0.67	0.48	0.29	0.53	0.71	0.69	0.79	0.53	0.23	0.7	0.7	0.23	0.66	0.73
Cash And Short Term Investments	0.94	0.49	0.61	0.96	0.53	0.51	-0.49	-0.5	0.73	0.51	0.49		0.58	0.99	-0.04	0.72	0.67	0.36	0.67	1.0	0.21	0.91	0.04	0.46	0.44	0.37
Common Stock Shares Outstanding	0.71	0.67	0.92	0.63	0.87	0.42	-0.15	-0.94	0.66	0.15	0.67	0.58		0.56	0.23	0.77	0.99	0.74	0.94	0.61	0.33	0.73	0.46	0.26	0.79	0.64
Short Term Investments	0.93	0.49	0.58	0.95	0.54	0.47	-0.56	-0.49	0.69	0.57	0.48	0.99	0.56		-0.03	0.72	0.65	0.35	0.66	0.98	0.17	0.9	0.08	0.43	0.39	0.36
Non Current Liabilities Total	0.06	0.37	0.17	-0.09	0.31	0.03	0.33	-0.22	0.14	-0.28	0.29	-0.04	0.23	-0.03		0.33	0.16	0.78	0.3	-0.05	-0.23	-0.07	0.35	0.3	0.23	0.04
Other Current Assets	0.73	0.58	0.7	0.66	0.75	0.31	-0.14	-0.71	0.62	0.14	0.53	0.72	0.77	0.72	0.33		0.79	0.67	0.8	0.69	0.14	0.69	0.28	0.77	0.58	0.46
Other Stockholder Equity	0.79	0.7	0.95	0.72	0.85	0.5	-0.19	-0.93	0.72	0.21	0.71	0.67	0.99	0.65	0.16	0.79		0.71	0.96	0.69	0.36	0.81	0.44	0.3	0.81	0.63
Total Liab	0.55	0.66	0.75	0.4	0.67	0.47	0.1	-0.69	0.63	-0.04	0.69	0.36	0.74	0.35	0.78	0.67	0.71		0.81	0.38	0.16	0.45	0.48	0.4	0.74	0.36
Property Plant And Equipment Gross	0.82	0.67	0.96	0.74	0.83	0.57	-0.17	-0.88	0.79	0.2	0.79	0.67	0.94	0.66	0.3	0.8	0.96	0.81		0.7	0.31	0.81	0.43	0.36	0.81	0.59
Total Current Assets	0.96	0.51	0.65	0.98	0.54	0.55	-0.5	-0.53	0.76	0.53	0.53	1.0	0.61	0.98	-0.05	0.69	0.69	0.38	0.7		0.24	0.93	0.07	0.4	0.48	0.39
Property Plant Equipment	0.26	0.23	0.51	0.26	0.06	0.65	-0.25	-0.35	0.6	0.27	0.23	0.21	0.33	0.17	-0.23	0.14	0.36	0.16	0.31	0.24		0.23	0.12	0.04	0.68	0.0
Net Tangible Assets	0.97	0.61	0.79	0.97	0.65	0.55	-0.43	-0.66	0.72	0.45	0.7	0.91	0.73	0.9	-0.07	0.69	0.81	0.45	0.81	0.93	0.23		0.25	0.32	0.55	0.59
Non Currrent Assets Other	0.21	0.83	0.42	0.13	0.68	0.11	0.06	-0.66	0.11	-0.09	0.7	0.04	0.46	0.08	0.35	0.28	0.44	0.48	0.43	0.07	0.12	0.25		-0.06	0.34	0.76
Other Assets	0.41	0.22	0.3	0.37	0.24	0.24	0.06	-0.2	0.41	-0.03	0.23	0.46	0.26	0.43	0.3	0.77	0.3	0.4	0.36	0.4	0.04	0.32	-0.06		0.31	0.05
Deferred Long Term Liab	0.61	0.61	0.91	0.52	0.54	0.78	-0.02	-0.77	0.86	0.1	0.66	0.44	0.79	0.39	0.23	0.58	0.81	0.74	0.81	0.48	0.68	0.55	0.34	0.31		0.29
Long Term Investments	0.48	0.75	0.55	0.46	0.83	0.07	-0.02	-0.76	0.2	-0.03	0.73	0.37	0.64	0.36	0.04	0.46	0.63	0.36	0.59	0.39	0.0	0.59	0.76	0.05	0.29

Click cells to compare fundamentals

Aclaris Therapeutics Account Relationship Matchups

Aclaris Therapeutics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	70.8M	251.2M	254.6M	197.4M	220.3M	175.4M
Other Current Liab	8.4M	11.6M	10.2M	2.2M	23.0M	24.2M
Total Current Liabilities	14.9M	22.9M	21.9M	31.0M	31.6M	17.8M
Total Stockholder Equity	37.7M	197.3M	197.6M	157.2M	155.6M	136.4M
Other Liab	2.4M	7.6M	28.8M	33.5M	38.5M	40.4M
Property Plant And Equipment Net	1.7M	1.3M	1.1M	1.6M	1.0M	1.6M
Net Debt	(42.9M)	(26.7M)	(44.6M)	(39.5M)	(24.6M)	(25.8M)
Retained Earnings	(504.5M)	(595.4M)	(682.3M)	(770.8M)	(902.9M)	(857.7M)
Accounts Payable	5.3M	10.0M	10.4M	8.9M	4.7M	7.1M
Cash	54.1M	27.3M	45.3M	39.9M	24.6M	23.3M
Non Current Assets Total	13.3M	46.2M	23.0M	68.5M	94.4M	99.1M
Cash And Short Term Investments	54.1M	225.7M	229.8M	119.1M	113.6M	136.6M
Common Stock Shares Outstanding	42.5M	56.7M	65.2M	69.8M	77.3M	42.4M
Short Term Investments	32.1M	164.1M	172.3M	79.2M	89.0M	96.4M
Liabilities And Stockholders Equity	70.8M	251.2M	254.6M	197.4M	220.3M	175.4M
Non Current Liabilities Total	18.3M	30.9M	35.0M	9.3M	33.2M	23.1M
Other Current Assets	5.2M	26.0M	13.5M	9.5M	12.0M	7.7M
Other Stockholder Equity	542.3M	793.0M	880.8M	928.1M	1.1B	551.3M
Total Liab	33.1M	53.9M	57.0M	40.2M	64.8M	39.0M
Property Plant And Equipment Gross	1.7M	4.7M	5.1M	5.8M	5.8M	3.1M
Total Current Assets	57.5M	205.0M	231.6M	128.9M	126.0M	139.1M
Accumulated Other Comprehensive Income	(94K)	(224K)	(897K)	(106K)	97K	101.9K
Property Plant Equipment	7.2M	1.7M	1.3M	1.1M	1.3M	1.9M
Net Tangible Assets	62.7M	30.5M	190.3M	190.6M	219.2M	135.0M
Non Currrent Assets Other	4.5M	3.6M	(630K)	1.7M	93.4M	98.0M
Other Assets	92K	4.5M	251.2M	1.7M	2.0M	1.9M
Net Receivables	772K	623K	484K	298K	318K	302.1K
Retained Earnings Total Equity	(453.5M)	(504.5M)	(595.4M)	(682.3M)	(614.1M)	(583.4M)
Capital Surpluse	523.5M	542.3M	793.0M	880.8M	1.0B	553.9M
Inventory	791K	5.0M	(34.2M)	(12.2M)	(11.0M)	(10.5M)
Intangible Assets	7.1M	7.0M	7.0M	269K	242.1K	230.0K
Non Current Liabilities Other	7.2M	30.6M	34.7M	9.3M	13.1M	13.2M
Short Long Term Debt Total	11.3M	693K	684K	426K	383.4K	364.2K
Capital Lease Obligations	603K	693K	684K	426K	489.9K	594.9K
Net Invested Capital	48.3M	197.3M	197.6M	157.2M	155.6M	129.6M
Net Working Capital	42.6M	182.1M	209.6M	97.9M	94.4M	102.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aclaris Stock Analysis

When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aclaris Historical Balance Sheet

Aclaris Therapeutics Inventory

(10.47 Million)

About Aclaris Balance Sheet Analysis

Aclaris Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Aclaris Therapeutics balance sheet Correlations

Aclaris Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aclaris Therapeutics balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Aclaris Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Short Term Investments	+ 0.99	Cash And Short Term Investments
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Total Current Assets	+ 0.98	Total Stockholder Equity
Total Current Assets	+ 0.98	Short Term Investments

Cash	- 0.99	Net Debt
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Other Stockholder Equity	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Other Liab
Property Plant And Equipment Gross	- 0.88	Retained Earnings
Retained Earnings	- 0.87	Total Current Liabilities